Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis

ESRD patients receiving hemodialysis (HD) were excluded from landmark trials evaluating direct-acting oral anticoagulants (DOACs) in atrial fibrillation (AF). The objective was to evaluate prescribing and bleeding with DOACs compared to warfarin in AF patients with chronic HD. A retrospective, obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Estella, Darais, Dallin, Fuji, Kevin, Nekola, Paige, Bashir, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151654/
https://www.ncbi.nlm.nih.gov/pubmed/32164234
http://dx.doi.org/10.3390/pharmacy8010037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151654/
https://www.ncbi.nlm.nih.gov/pubmed/32164234
http://dx.doi.org/10.3390/pharmacy8010037

Ejemplares similares